The United States has seen more people, especially older adults, catching up on medical procedures and routine checkups that were deferred due to pandemic-driven curbs. The increased medical care utilization has benefited U.S. lab testing companies, including Labcorp's rival Quest Diagnostics, which forecast strong 2024 sales, betting on demand for diagnostic kits.